Medirom Healthcare Technologies (MRM) Equity Average (2021 - 2025)
Historic Equity Average for Medirom Healthcare Technologies (MRM) over the last 5 years, with Q2 2025 value amounting to $3.9 million.
- Medirom Healthcare Technologies' Equity Average rose 95554.63% to $3.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.9 million, marking a year-over-year increase of 95554.63%. This contributed to the annual value of $3.8 million for FY2024, which is 65177.4% up from last year.
- Medirom Healthcare Technologies' Equity Average amounted to $3.9 million in Q2 2025, which was up 95554.63% from $1.9 million recorded in Q4 2024.
- In the past 5 years, Medirom Healthcare Technologies' Equity Average ranged from a high of $3.9 million in Q2 2025 and a low of -$2.4 million during Q2 2022
- In the last 5 years, Medirom Healthcare Technologies' Equity Average had a median value of -$627796.0 in 2023 and averaged $247555.4.
- As far as peak fluctuations go, Medirom Healthcare Technologies' Equity Average tumbled by 17362.89% in 2022, and later skyrocketed by 95554.63% in 2025.
- Quarter analysis of 5 years shows Medirom Healthcare Technologies' Equity Average stood at $3.3 million in 2021, then crashed by 152.17% to -$1.7 million in 2022, then skyrocketed by 53.49% to -$798759.8 in 2023, then skyrocketed by 337.78% to $1.9 million in 2024, then skyrocketed by 105.79% to $3.9 million in 2025.
- Its Equity Average stands at $3.9 million for Q2 2025, versus $1.9 million for Q4 2024 and -$456832.2 for Q2 2024.